Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by MoneyCristoon Mar 23, 2018 9:54pm
166 Views
Post# 27774223

1st to market is extremely important

1st to market is extremely importantThose saying the contrary are the one that do not know much about pharma, and about marketing in general. When you are first to market you secure your way to customers who will reluctantly change something working for something they're not sure of. Plus when you are first to market you do not have to fight to dislodge competing products. I would go as far as saying that a slightly less performing product, would do better if it is first to access market, securing doctor training, awareness and patient habit would make difficult for a similar product to compete once those are established, unless the product 2nd to finish line is in a new stellar league compared to the first one, otherwise, similar product 1st coming is winning, basic marketing101
Bullboard Posts